ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Activity

28 hedge funds and large institutions have $8.45M invested in Oramed Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+7
Holders Change %
+33.33%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
8
Increased
6
Reduced
4
Closed
1
Calls
$4K
Puts
$4K
Net Calls
–
Net Calls Change
+$6K

Top Buyers

1
SM
1
Sabby Management
Florida
$3.88M
2
AC
2
Armistice Capital
New York
$3.04M
3
Northern Trust
3
Northern Trust
Illinois
$88K
4
Group One Trading
4
Group One Trading
Illinois
$82K
5
Squarepoint
5
Squarepoint
New York
$71K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$199K
2
UBS Group
2
UBS Group
Switzerland
$16K
3
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$8K
4
LC
4
Landaas & Company
Wisconsin
$0
5
Morgan Stanley
5
Morgan Stanley
New York
$143K
Name Holding Trade Value Shares
Change 		Shares
Change %
LTFS
26
Ladenburg Thalmann Financial Services
Florida
$2K – – –
Simplex Trading
27
Simplex Trading
Illinois
$2K +$2K +547 New
SPIA
28
Steward Partners Investment Advisory
New York
$1K – – –
LC
29
Landaas & Company
Wisconsin
– -$2K -230 Closed
1
2